openPR Logo
Press release

U.S. Biosimilars Market: Coronavirus Impact - Key Takeaways F. Hoffmann-La Roche Ltd., AbbVie Inc., Merck & Co., Celltrion Inc., Coherus BioSciences, Inc., Teva Pharmaceutical Industries Ltd., Eli Lilly and Company

04-24-2020 10:13 AM CET | Health & Medicine

Press release from: Fortune Business Insights Pvt. Ltd

U.S. Biosimilars Market: Coronavirus Impact - Key Takeaways F.

The "U.S. Biosimilars Market 2020" will gain momentum from the increasing government support to adopt biosimilars in the healthcare sectors. According to a report by Fortune Business Insights, titled, "Biosimilars: U.S. Market Analysis, Insights and Forecast, 2019-2026," The U.S. Biosimilars Market is projected to reach US$ 17,696.0 Mn by 2026. The report provides valuable insights into the drivers influencing growth of the market. As per the report, The U.S. Biosimilars Market is anticipated to report an impressive CAGR of 54.7% during the forecast period. The report also states that the U.S. market was valued at US$ 436.1 Mn in 2018.

Leading Players operating in the U.S. Biosimilars Market are:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:

Hoffmann-La Roche Ltd.,
AbbVie Inc.,
Merck & Co.,
Celltrion Inc.,
Coherus BioSciences, Inc.,
Teva Pharmaceutical Industries Ltd.,
Eli Lilly and Company
Get Sample PDF Brochure: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/u-s-biosimilars-market-100990

Autoimmune Diseases Segment Projected to Dominate the Market in the U.S.

The U.S. biosimilars market is classified into three segments, namely, by distribution channel, by disease indication, and by drug class. By distribution channel, the market is grouped into online pharmacy, hospital pharmacy, and retail pharmacy. In terms of disease indication, the market is divided into cancer and autoimmune diseases such as arthritis, neutropenia, psoriasis, and others. In 2018, the autoimmune diseases held a market share of 92.0%. The segment is anticipated to remain in the leading position the U.S. biosimilars market during the forecast period. Factors like increasing adoption of biosimilars, rise in the prevalence of autoimmune diseases, and availability of limited drugs are likely to boost the segment. The Centers of Disease Control and Prevention declared that approximately 26% adults are estimated to have arthritis by 2040.

An Overview of the Impact of COVID-19 on this Market:

The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.

We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.

Click here to get the short-term and long-term impact of COVID-19 on this Market Please visit: https://www.fortunebusinessinsights.com/industry-reports/u-s-biosimilars-market-100990

Market Segmentation:

By Drug Class

Filgrastim & Pegfilgrastim
Monoclonal Antibodies
Others
By Disease Indication

Cancer
Autoimmune Diseases
Arthritis
Psoriasis
Neutropenia
Others
Others
By Distribution Channel

Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/u-s-biosimilars-market-100990

Detailed Table of Content:

Introduction
1.1. Research Scope

1.2. Market Segmentation

1.3. Research Methodology

1.4. Definitions and Assumptions

Executive Summary
Market Dynamics
3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities

Key Insights
4.1 Prevalence of Key Disease Associated with the Scope - U.S., 2018

4.2 New Product Launch

4.3 Pipeline Analysis

4.4 Regulatory Scenario

4.5. Reimbursement Scenario

4.6. Patent Snapshot of Biologics

4.6 Key Industry Developments - Partnerships, Mergers & Acquisitions

U.S. Biosimilars Market Analysis, Insights and Forecast, 2015-2026
5.1. Key Findings / Summary

5.2. Market Analysis, Insights and Forecast - By Drug Class

5.2.1 Filgrastim & Pegfilgrastim

5.2.2 Monoclonal Antibodies

5.2.2 Others

5.3. Market Analysis, Insights and Forecast - By Disease Indication

5.3.1 Cancer

5.3.2 Autoimmune Diseases

5.3.2.1 Arthritis

5.3.2.2 Psoriasis

5.3.2.3 Neutropenia

5.3.2.4 Others

5.3.3 Others

5.4. Market Analysis, Insights and Forecast - By Distribution Channel

5.4.1 Hospital Pharmacy

5.4.2 Retail Pharmacy

5.4.3 Online Pharmacy

Competitive Analysis
6.1. Key Industry Developments

6.2. U.S. Market Share Analysis (2018)

6.3. Competition Dashboard

6.4. Comparative Analysis - Major Players

6.5. Company Profiles (Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability))

6.5.1 Novartis AG

6.5.2 Pfizer Inc.

6.5.3 Coherus BioSciences, Inc.

6.5.4 Teva Pharmaceutical Industries Ltd.

6.5.5 Merck & Co., Inc.

6.5.6 AbbVie Inc.

6.5.7 F. Hoffmann-La Roche Ltd.

6.5.8 Eli Lilly and Company

6.5.9 Celltrion Inc.

6.5.10 Amgen Inc.

6.5.11 Other Prominent Players

Strategic Recommendations
Continued...

Reasons to Purchase this Report:

Comprehensive analysis of the U.S. Biosimilars Market growth drivers, obstacles, opportunities, and other related challenges.
Tracks the developments, such as new product launches, agreements, mergers and acquisitions, geographical expansions, and joint ventures.
Identifies market restraints and boosters.
Identifies all the possible segments present in the market to aid organizations in strategic business planning.
KEY QUESTIONS ANSWERED:

What are the key technological and U.S. Biosimilars Market trends shaping the market?
What are the key opportunities in the market?
What are the key companies operating in the market?
Which company accounted for the highest market share?
Why Choose Fortune Business Insights?
What is the market size and growth rate of the global and regional market by various segments?
What is the market size and growth rate of the market for selective countries?
Which region or sub-segment is expected to drive the market in the forecast period?
What Factors are estimated to drive and restrain the U.S. Biosimilars Market growth?

About Us:

Fortune Business Insights(TM) offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

Contact Us:

Fortune Business Insights(TM) Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune - 411045, Maharashtra, India.

Phone:

US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email:sales@fortunebusinessinsights.com

Linkedin | Twitter | BLogs

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release U.S. Biosimilars Market: Coronavirus Impact - Key Takeaways F. Hoffmann-La Roche Ltd., AbbVie Inc., Merck & Co., Celltrion Inc., Coherus BioSciences, Inc., Teva Pharmaceutical Industries Ltd., Eli Lilly and Company here

News-ID: 2023415 • Views: …

More Releases from Fortune Business Insights Pvt. Ltd

Wheat Flour Market Size, Share, Latest Trends, Top Companies and Forecast by 2028 | Ardent Mills , Wudeli Flour Mill Group, ADM Company , General Mills, Allied Pinnacle Pty Ltd., Manildra Milling Pvt. Ltd.
Wheat Flour Market Size, Share, Latest Trends, Top Companies and Forecast by 202 …
The global Wheat Flour Market Size is expected to rise with an impressive CAGR and generate the highest revenue by . Fortune Business Insights™ in its latest report published this information. The report is titled Wheat Flour Market Size, Share & Trends, ". The report discusses research objectives, research scope, methodology, timeline and challenges during the entire forecast period. The global wheat flour market size was USD 155.08 billion in 2020…
Vanilla Extracts Market Size, Latest Trends, Revenue, Growth, Top Companies and Forecast by 2029 | Adams Extract (U.S.), C.F. Sauer Company (U.S.), McCormick & Company (U.S.), Frontier Natural Products (U.S.), Madécasse (U.S.), Nielsen-Massey Vanillas (U
Vanilla Extracts Market Size, Latest Trends, Revenue, Growth, Top Companies and …
The global Vanilla Extracts Market Size is expected to rise with an impressive CAGR and generate the highest revenue by . Fortune Business Insights™ in its latest report published this information. The report is titled Vanilla Extracts Market Size, Share & Trends, ". The report discusses research objectives, research scope, methodology, timeline and challenges during the entire forecast period. The global vanilla extract market size was valued at USD 5.26 billion…
Hummus Market Share, Size, Top Companies, Latest Trends and Forecast by 2021-2028 | Nestlé S.A. (Vevey, Switzerland), Cedar's Mediterranean Foods, Inc. (Massachusetts, U.S.), Haliburton International Foods, Inc. (California, U.S.), Strauss Group, Ltd. (S
Hummus Market Share, Size, Top Companies, Latest Trends and Forecast by 2021-202 …
The global Hummus Market Size is expected to rise with an impressive CAGR and generate the highest revenue by . Fortune Business Insights™ in its latest report published this information. The report is titled Hummus Market Size, Share & Trends, ". The report discusses research objectives, research scope, methodology, timeline and challenges during the entire forecast period. The global hummus market size was USD 2.62 billion in 2020 and is projected…
Frozen Food Market Trends, Size, Share, Growth and Forecast by 2028 | McCain Foods, Wawona Frozen Foods, ConAgra Foods, Inc. and Nestle S.A.
Frozen Food Market Trends, Size, Share, Growth and Forecast by 2028 | McCain Foo …
The global Frozen Food Market Size is expected to rise with an impressive CAGR and generate the highest revenue by . Fortune Business Insights™ in its latest report published this information. The report is titled Frozen Food Market Size, Share & Trends, ". The report discusses research objectives, research scope, methodology, timeline and challenges during the entire forecast period. The global frozen food market size was USD 231.38 billion in 2020…

All 5 Releases


More Releases for Biosimilars

Global Biosimilars Market 2021-2028 | Price Advantage of Biosimilars Over Biolog …
The global Biosimilars market focuses on encompassing major statistical evidence for the Biosimilars industry as it offers our readers a value addition on guiding them in encountering the obstacles surrounding the market. A comprehensive addition of several factors such as global distribution, manufacturers, market size, and market factors that affect the global contributions are reported in the study. In addition, the Biosimilars study also shifts its attention with an in-depth…
Growth of the Biosimilars Market Is Mainly Driven by Increasing Number of Approv …
A biosimilar is a biologic medical product that is similar to another already approved biological medicine, in terms of quality, safety, and efficacy. Biosimilars are a class of therapeutic drugs that provide additional treatment options and help reduce healthcare costs. Thus, there is an increasing demand for biosimilar drugs due to increasing prevalence of autoimmune diseases, key factor driving the growth of the biosimilars market. According to the National Stem…
Global Oncology Biosimilars Market | Global Oncology Biosimilars Industry | Onco …
The oncology biosimilars market involves of sales of medicine and drug interrelated products for cancer treatment. Biosimilars are pharmaceuticals which are produced using cell lines and are fashionable to the manufacturer. The manufacturing of such cell line processes is a multipart and time-consuming procedure. According to the report analysis, ‘Oncology Biosimilars Market Global Report 2020-30’ states that the worldwide oncology biosimilars market was worth USD 2990.34 million in 2019. It is…
Global Biosimilars Market | Global Biosimilars Industry | Global Biosimilars Mar …
The biosimilars market involves of sales of biosimilars and associated services that are cast-off to treat chronic sicknesses such as diabetes, arthritis, and cancer. The Biosimilars are pharmaceuticals that are produced using cell lines and offers no clinical difference as linked to biologics. The Biosimilars are made once the patent of biologics is deceased. According to the report analysis, ‘Biosimilars Market Global Report 2020-30’ states that the worldwide biosimilars market was…
Global Oral Biologics and Biosimilars Market | Global Oral Biologics and Biosimi …
The oral biologics and biosimilar market contain of sales of oral biologics and biosimilar products and associated services utilized to treat chronic syndromes such as diabetes, arthritis, cancer. Biologics are drugs completed from living cells using exceedingly complex technology while biosimilars are generated to function similarly to biologics but are not matching to biologics. Biosimilars offer energetic properties as any licensed biologic drug. The oral biologics and biosimilar market encompass…
Insulin Biosimilars Market, by Biosimilar Type Rapid-acting Biosimilars, Long-ac …
Diabetes is a group of metabolic disease characterized by high blood sugar level due to inadequate secretion of insulin. Common symptoms of diabetes include increased hunger, tiredness, weight loss, and excessive thirst and urination. The prevalence of diabetes is increasing, in turn, boosting demand for insulin biosimilar. For instance, according the World Health Organization (WHO) report in 2014, globally around 422 million adults were living with diabetes and 1.5 million…